Peptide record

TPDB87825

Lanreotide Selfassembly modified_plain modified
8 amino acids
Basic Information
TPDB87825
Lanreotide
Selfassembly
Self-assembling and biomaterial peptides
PMC
modified_plain
Yes
A 8-aa modified selfassembly peptide sequence curated from PMC, without an available 3D structural model.
Modified, details unspecified
Sequence
D-beta-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr
Physicochemical Analysis
C145H221N41O48S2
QGIKMFW
TY
3370.72
7.00
4
3
11
-0
3.33
-0.418
44.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
6085
180.53
14
Residue Composition
number
3
A
3
R
1
N
2
D
2
C
1
E
0
Q
0
G
1
H
0
I
3
L
0
K
0
M
0
F
1
P
3
S
4
T
0
W
4
Y
1
V
Amino Acid Distribution
A: 3 R: 3 N: 1 D: 2 C: 2 E: 1 Q: 0 G: 0 H: 1 I: 0 L: 3 K: 0 M: 0 F: 0 P: 1 S: 3 T: 4 W: 0 Y: 4 V: 1
Chemical Descriptors
8
C145H221N41O48S2
3370.72
7.00
-0
3.33
-0.418
Self-Assembly Information 1 records
Record 1 PMC

Source

34884670
10.3390/ijms222212662
Self-Assembling Peptides: From Design to Biomedical Applications

Self-Assembly

Nanostructure formation
Nanotubes
Aqueous depot formulation
Selfassembly; Nanostructure=Nanotubes; Trigger=Aqueous depot formulation
Review table reports marketed self-assembled peptide and nanotube aggregation type
Neuroendocrine tumors
active peptide
PMC
Selfassembly
Evidence Records 1 records
Evidence 1 Selfassembly

Activity

Nanostructure formation
Selfassembly Nanostructure=Nanotubes Trigger=Aqueous depot formulation
Nanotubes

Source & Reference

NA
PMC
10.3390/ijms222212662

Other

D-beta-Nal D-Trp disulfide/cyclic peptide
Neuroendocrine tumors
active peptide
Aqueous depot formulation
Review table reports marketed self-assembled peptide and nanotube aggregation type
34884670
Self-Assembling Peptides: From Design to Biomedical Applications
Sequence contains D-beta-Nal plain Sequence uses X as noncanonical placeholder. Marketed self-assembling peptide listed in review Table 1.
Additional Detail Fields 7 fields
Aqueous depot formulation
D-beta-Nal D-Trp disulfide/cyclic peptide
Sequence contains D-beta-Nal plain Sequence uses X as noncanonical placeholder. Marketed self-assembling peptide listed in review Table 1.
34884670
Self-Assembling Peptides: From Design to Biomedical Applications
Neuroendocrine tumors
active peptide